Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroko Saito

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2011
[PARP inhibitors for cancer therapy]Hiroko Saito, Yoshio Miki
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 29, 2013
[Gene expression profiling studies in breast cancer]Hiroko Saito, Yoshio Miki
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2013
[PARP (poly(ADP-ribose) polymerase) family]Hiroko Saito, Yoshio Miki
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 29, 2013
[Mechanisms of human breast cancer tumorigenesis: outline (including the molecular mechanism and multi-step of breast carcinogenesis)]Hiroko Saito, Yoshio Miki
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 29, 2013
[Problem of the hereditary breast cancer screening; including the genetic diagnosis]Hiroko Saito, Yoshio Miki
Patient Education and Counseling|April 13, 2021
Assessing the quality of cancer screening leaflets using the International Patient Decision Aids Standards instrument: A cross-sectional content analysisYuki Furukawa, Hiroko Saito, Kazuo Hasegawa, et al.
Development (Cambridge, England)|January 19, 2021
CAMSAP3 is required for mTORC1-dependent ependymal cell growth and lateral ventricle shaping in mouse brainsToshiya Kimura, Hiroko Saito, Miwa Kawasaki, et al.
Sangyo Eiseigaku Zasshi = Journal of Occupational Health|August 14, 2015
[A smear method for measuring anti-cancer drugs residues in hospitals]Takumi Takano, Shigeru Suzuki, Ikuto Tsukiyama, et al.
Biochemical and Biophysical Research Communications|March 8, 2021
CDK1 inhibitor controls G2/M phase transition and reverses DNA damage sensitivityShigeaki Sunada, Hiroko Saito, Doudou Zhang, et al.
The American Journal of Pathology|August 26, 2003
Association between mitotic spindle checkpoint impairment and susceptibility to the induction of apoptosis by anti-microtubule agents in human lung cancersAkira Masuda, Ken Maeno, Taku Nakagawa, et al.
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Gan to Kagaku Ryoho. Cancer & Chemotherapy|March 4, 2011
[PARP inhibitors for cancer therapy]Hiroko Saito, Yoshio Miki
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 29, 2013
[Gene expression profiling studies in breast cancer]Hiroko Saito, Yoshio Miki
Nihon Rinsho. Japanese Journal of Clinical Medicine|March 22, 2013
[PARP (poly(ADP-ribose) polymerase) family]Hiroko Saito, Yoshio Miki
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 29, 2013
[Mechanisms of human breast cancer tumorigenesis: outline (including the molecular mechanism and multi-step of breast carcinogenesis)]Hiroko Saito, Yoshio Miki
Nihon Rinsho. Japanese Journal of Clinical Medicine|January 29, 2013
[Problem of the hereditary breast cancer screening; including the genetic diagnosis]Hiroko Saito, Yoshio Miki
Patient Education and Counseling|April 13, 2021
Assessing the quality of cancer screening leaflets using the International Patient Decision Aids Standards instrument: A cross-sectional content analysisYuki Furukawa, Hiroko Saito, Kazuo Hasegawa, et al.
Development (Cambridge, England)|January 19, 2021
CAMSAP3 is required for mTORC1-dependent ependymal cell growth and lateral ventricle shaping in mouse brainsToshiya Kimura, Hiroko Saito, Miwa Kawasaki, et al.
Sangyo Eiseigaku Zasshi = Journal of Occupational Health|August 14, 2015
[A smear method for measuring anti-cancer drugs residues in hospitals]Takumi Takano, Shigeru Suzuki, Ikuto Tsukiyama, et al.
Biochemical and Biophysical Research Communications|March 8, 2021
CDK1 inhibitor controls G2/M phase transition and reverses DNA damage sensitivityShigeaki Sunada, Hiroko Saito, Doudou Zhang, et al.
The American Journal of Pathology|August 26, 2003
Association between mitotic spindle checkpoint impairment and susceptibility to the induction of apoptosis by anti-microtubule agents in human lung cancersAkira Masuda, Ken Maeno, Taku Nakagawa, et al.
Pageof 8